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Summary 
Mice unable to synthesize dopamine (DA) specifically 
in dopaminergic neurons were created by inactivating 
the tyrosine hydroxylase (TH) gene then by restoring 
TH function in noradrenergic cells. These DA-deficient 
(DA-‘-) mice were born at expected frequency but be- 
came hypoactive and stopped feeding a few weeks 
after birth. Midbrain dopaminergic neurons, their pro- 
jections, and most characteristics of their target neu- 
rons in the striatum appeared normal. Within a few 
minutes of being injected with L-dihydroxyphenyla- 
lanine (L-DOPA), the product of TH, the DA-‘- mice be- 
came more active and consumed more food than con- 
trol mice. With continued administration of L-DOPA, 
nearly normal growth wasachieved. These studies indi- 
cate that DA is essential for movement and feeding, 
but is not required for the development of neural cir- 
cuits that control these behaviors. 
Introduction 
Dopamine (DA) is one of the classical neurotransmitters 
of the central nervous system (CNS). About 75% of the 
dopaminergic neurons have their cell bodies in the sub- 
stantia nigra of the midbrain and project to the striatum 
(Carlsson, 1959; Dahlstrom and Fuxe, 1964; Lindvall and 
Bjorlund, 1983). These neurons have been implicated in 
the regulation of motor behavior in part because their de- 
generation is thought to underlie Parkinson’s disease 
(Hornykiewicz, 1966). Another distinct dopaminergic sys- 
tem arises in the ventral tegmental area of midbrain and 
projects to the nucleus accumbens, olfactory tubercule, 
and frontal cortex. These pathways are thought to influ- 
ence motivated behaviors, including activities related to 
reward (Koob, 1992; Self and Nestler, 1995). Dysfunction 
of this system has been implicated in depression and 
schizophrenia (Seeman et al., 1993). 
DA is synthesized from tyrosine by the sequential ac- 
tions of tyrosine hydroxylase (TH), which generates L-dihy- 
droxyphenylalanine (L-DOPA), and L-aromatic amino acid 
decarboxylase (AADC). DA is actively transported into syn- 
aptic vesicles by a vesicular amine transporter (Liu et al., 
1992b). When DA is released, it can bind to membrane 
receptors that are coupled to trimeric G proteins; the most 
prominent are the Dl and D2 receptors, which stimulate 
and inhibit adenylyl cyclase, respectively (Civelli et al., 
1993). DA is cleared from synapses by plasma membrane 
transporters and then either degraded by monoamine oxi- 
dases or recycled into synaptic vesicles (Amara and Ku- 
har, 1993). The membrane transporters are the primary 
site of action of antidepressants and addictive drugs such 
as cocaine and amphetamine. 
Our knowledge of the behavioral functions of DA in the 
CNS is derived primarily from studies with DA receptor 
ligands and neurotoxins. For example, blocking or stimu- 
lating postsynaptic DA receptors reduces or increases lo- 
comotion and exploratory behavior, respectively (Arnt, 
1987; Clark and White, 1987). Likewise, increasing synap- 
tic DA concentration by inhibiting DA transporters or 
blocking DA autoreceptors stimulates locomotion (Arnt, 
1987; Woolverton and Johnson, 1992). Blocking DA recep- 
tors attenuates the rewarding actions of food, intracranial 
self-stimulation, and psychomotor stimulants (Fibiger and 
Phillips, 1988; Koob, 1992; Wise and Hoffman, 1992). Bi- 
lateral lesions of midbrain dopaminergic pathways of adult 
rats with 6-hydroxydopamine (6-OHDA) result in long- 
lasting adipsia, aphagia, hypoactivity, and loss of explor- 
atory behavior (Ungerstedt, 1971). The neurotoxin l-methyl- 
4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) preferentially 
destroys DA neurons in the substantia nigra and produces 
symptoms that resemble Parkinson’s disease (Kopin and 
Markey, 1988). While these approaches have produced 
a general understanding of DA function, they have limita- 
tions due to incomplete blockade, nonspecific effects on 
other neuronal systems, or loss of cellular components in 
addition to DA. Furthermore, most of these studies have 
been restricted to adult animals. Relatively little is known 
about the role of DA in development. DA and its receptors 
appear in the brain between embryonic day 10 (ElO) and 
El5 in rodents (Voorn et al., 1988; Schambra et al., 1994) 
and a number of experiments suggested that DA signaling 
could play a role in establishing synaptic connections (Lank- 
ford et al., 1988; Rodrigues and Dowling, 1990; Todd, 1992; 
Lauder, 1993). 
We provide genetic evidence in this report that DA is 
essential for proper CNS functions such as drinking, feed- 
ing, and movement, but is not required for the develop- 
ment of neural circuits involved in these behaviors. 
Results 
Targeting TH-Coding Sequence to Dopamine- 
p-Hydroxylase Promoter and Generation of 
DA- and Norepinephrine-Deficient Mice 
We previously disrupted the TH gene in mice (Zhou et 
al., 1995), which resulted in deficiency in both DA and 
norepinephrine (NE). To restore the expression of the TH 
gene in noradrenergic neurons, the TH coding sequence 
was targeted to the noradrenergic-specific dopamine- 
6-hydroxylase (DBH) promoter by homologous recombina- 
tion in embryonic stem (ES) cells. Figure 1A shows the 
structure of the targeting vector, pDBH-TH. Out of 660 ES 
cell clones, two clones with predicated genomic structure 
were identified by Southern blot analysis (data not shown). 
Both ES cell clones were separately microinjected into 
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Figure 1. Gene Targeting, Mating Strategy. 
and Genetic Diagnosis of DA-‘- Mice 
(A) The murine DBH gene and targeting vector 
pDBH-TH. A region of the DBH gene that in- 
cludes the proximal promoter is shown. The 
entire TH coding region, including 1 kb se- 
quence after the polyadenylation site and a neo 
cassette, was inserted between exons 1 and 2 
of the DBH gene. Locations of probes from 
DBH gene (box a) and the TH gene (box b) that 
were used for screening ES cell clones and 
mice are indicated. Abbreviations: B, BamHI; 
H, Hindlll; Sf, Sfi; X, Xba; S, artifical Sall; PBS, 
pBluescript (Strategene). 
(B) Breeding strategy for generating DA-‘- 
mice. 
(C) Southern blot analysis of representative tail 
DNA samples. DNA was digested with Xbal 
and hybridized with probe b from the TH gene. 
The 2.7 kb band is the wild-type @VT) TH allele, 
the 4.5 kb band is the disrupted TH allele, and 
the 7.1 kb band represents the DBH-TH allele. 
The faint 5.5 kb band is due to partial digestion. 
blastocysts, and one produced chimeras that transmitted 
the DBH-TH transgene via the germline. 
DBH-TH transgenic mice were used to produce off- 
spring with selective NE or DA deficiency. When heterozy- 
gous DBH-TH+‘- mice were intercrossed, the homozygous 
DBH-TH”’ mice were deficient in DBH function and had 
a phenotype indistinguishable from DBH-‘- mice (Thomas 
et al., 1995). Figure 1B shows the strategy of generating 
DA-‘- mice. DBH-TH+‘- mice were first crossed with TH+‘- 
mice to generate TH+‘-DBH-TH+‘- mice. These compound 
heterozygotes were then crossed with TH+/- mice to gener- 
ate mice of six different genotypes that can be distin- 
guished by Southern blots of Xbal-digested DNA using 
probe bfrom theTHgene(Figure 1A). Figure 1Cshowsthe 
pattern of hybridization bands for five of the six genotypes. 
The TH-‘- genotype is not represented because most TH-‘- 
mutants die in utero (Zhou et al., 1995). For simplicity, we 
refer to mice with the genotype of TH-‘-DBH-TH+‘- as DA-‘-. 
Restoration of NE in Noradrenergic Cells 
of TH-‘- Mice 
We predicted that the DBH-TH gene would restore the 
ability to synthesize DA and NE in cells that normally ex- 
press DBH (noradrenergic cells) when introduced into the 
TH-” genetic background. In peripheral organs that are 
innervated by sympathetic neurons such as the heart, 
there are normally high levels of NE but little DA (Figure 
2A). In TH-‘- mice, neither DA nor NE was detected. How- 
ever, NE levels were restored in heart (Figure 2A), salivary 
glands, and adrenal glands (data not shown) of DA-‘- mice. 
Both DA and NE are abundant in the brains of wild-type 
mice but absent in TH-‘- mice (Figure 28). NE levels were 
restored in the brains of DA-‘- mice, but DA remained low 
(Figure 28). 
To determine where TH was expressed in the brain of 
DA-‘- mice, we performed immunocytochemistry with an 
antibody to TH. Figure 3F shows that TH immunoreactivity 
was observed only in noradrenergic neurons of the locus 
ceruleus in DA-‘- mice, but not in midbrain DA neurons 
(Figure 3D), nor in their terminals in the telencephalon, 
including caudate putamen, nucleus accumbens, and ol- 
factory tubercle (Figure 38). In wild-type brains, TH immu- 
noreactivity was present in all three regions (Figures 3A, 
3C, and 3E). TH immunoreactivity and catecholamine his- 
tofluorescence were also restored in the adrenal medulla 
of DA-‘- mice (data not shown). 
The DBH-TH Transgene Prevents the Embyonic 
Fatality of TH-‘- Mice 
In crosses of TH+‘-DBH-TH+‘+ mice with TH+‘- mice, we 
expected 25% of the offspring to be TH-‘- and 50% of 
them to have the DBH-TH gene. Because most TH-‘- mice 
die in utero (Zhou et al., 1995), we expected one seventh 
of mice born (see Figure 1 B) to be DA-‘-, if dopaminergic 
function was not required prior to birth. In fact, 114 out of 
789 mice born were DA-‘-, indicating that the DBH-TH 
transgene rescued the embryonic fatality of TH-‘- mutants. 
Early Postnatal Fatality of DA-‘- Mice 
and Rescue by L-DOPA 
Newborn DA-‘- mice were grossly indistinguishable from 
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Figure 2. Catecholamine Levels in the Heart and the Brain 
DA and NE levels from the heart (A) and brain (B) of P16 wild-type 
(n = I), TH-‘- (n = l), and untreated DA-’ (n = 2) mice were measured 
by high pressure liquid chromatography and electrochemical detection 
(Thomas et al., 1995). 
they were recognizable by their smaller size, hypoactivity, 
poorly groomed coats, and hunched posture. Neurological 
tests revealed that 16-day-old DA-‘+ mice had normal re- 
flexion, corneal, startle, righting, grasping, and placing 
reflexes (assessed according to Drago et al., 1994). DA-‘- 
mice could balance on a stationary bar, and no tremor 
was observed. At P16, their weight was 70% of littermates, 
but their growth rate became negative after P17, and they 
all died by 4 weeks of age (Figures 4A and 46). 
We attempted to rescue DA-/+ mice with L-DOPA, the 
product of TH enzymatic activity. L-DOPA was adminis- 
tered intraperitoneally, usually beginning at P15, when 
DA-‘- pups were easily recognized. L-DOPA, at a dose of 
50 mglkg twice a day, rescued all DA-‘- mice to adulthood 
(Figure 4A). Such treatment restored nearly normal growth 
rate of DA-‘- mice (Figure 4A). At 7 weeks of age, DA-‘- 
female mice weighed 17.6 + 0.77 g (mean f SEM; n = 
9) while their littermates weighed 20.9 f 1.2 g (n = 7). 
To date, more than 50 DA-‘- mice have been rescued to 
adulthood. 
Survival of DA-Containing Pathways 
in the Absence of DA 
Do dopaminergic neurons survive in DA+ mice? This 
question was addressed by immunostaining with an anti- 
body against AADC, the enzyme that converts L-DOPA 
to DA. AADC-positive cells were found in the midbrain 
(Figure 5D), olfactory bulb, and hypothalamus (data not 
shown) of DA-‘- mice, where dopaminergic neurons nor- 
mally exist. AADC immunoreactivity was also found in the 
normal dopaminergic targets in the striatum, such as cau- 
date putamen, nucleus accumbens, and olfactory tubercle 
(Figure5B) while noTH immunoreactivity wasobserved in 
nearby sections from DA-‘- mice (see Figure 38). Sagittal 
sections were immunostained with both TH and AADC 
antisera to demonstrate the fiber pathway of midbrain do- 
paminergic neurons to their targets in the telencephalon. 
No TH immunoreactivity was observed in midbrain dopa- 
minergic neurons, the medial forebrain bundle, orthe stria- 
turn of DA-‘- mice (Figure 5F). However, when the antibody 
against AADC was used, similar immunostaining patterns 
were observed in DA-‘- and wild-type brains (Figures 5G 
and 5H). These studies demonstrate that both midbrain 
DA neurons and their terminals in the telencephalon ap- 
pear normal in DA-/- mice. 
Normal Neurogenesis of the Striatum 
in the Absence of DA 
Several approaches were used to determine the effects 
of DA deficiency on neural differentiation of the striatum, 
a major target of midbrain DA neurons. First, sections were 
stained with cresyl violet (Figures 6A and 66) and by the 
Nissl and Homer’s silver methods (data not shown). There 
were no obvious anatomical changes in the brains of DA-‘- 
mice as compared with wild-type mice, except that the 
size of the mutant brain was reduced and the neurons 
were slightly more compact. Second, the expression of 
Dl and D2 receptor mRNA was examined by in situ hybrid- 
ization with digoxygenin-labeled probes. Figures 6F and 
6H show that both Dl and D2 receptor mRNAs were ex- 
pressed in the mutant striatum and that the pattern and 
intensities of hybridization were indistinguishable from 
wild-type striatum. Third, sections were stained for 
DARPP32 (DA- and cyclic AMP-regulated phosphopro- 
tein), a protein whose phosphorylation is regulated by Dl 
receptor stimulation (Hemmings and Greengard, 1986). 
Figure 6D shows that there was widespread DARPP32 
staining in the DA-/- striatum and that the intensity was 
similar to wild-type controls (Figure 6C). Other sites of 
DARPP32 expression, such as the deep layers of the cere- 
bral cortex, were also similar (Figures 6C and 6D). Quanti- 
tative analysis of DARPP32 by Western blot revealed the 
same level of DARPP32 in DA-/- and wild-type striatum 
(data not shown). About 90% of striatal neurons use 
y-aminobutyric acid (GABA) as their principal neurotrans- 
mitter (Kita and Kitai, 1988). Western blots revealed that 
the levels of GAD65 and GAD67, the enzymes responsible 
for the synthesis of GABA, in the mutant striatum were 
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the same as those of wild type (data not shown). Taken 
together, these results indicate that neurogenesis in the 
striatum is essentially normal in the absence of DA. 
Reduced Substance P and Dynorphin Expression 
in DA-‘- Striatum 
Substance P, dynorphin, and enkephalin are the primary 
neuropeptides found in the striatal projection neurons that 
expresseither Dl or D2 receptors (Graybiel, 1990; Gerfen, 
1992). Studies of rodents and primates treated with neuro- 
toxins or with DA receptor antagonists indicated that the 
expression of neuropeptides in the striatum may be con- 
trolled by DA signaling (Anderson and Reiner, 1990; Ger- 
fen et al., 1990). To assess whether the expression of 
neuropeptides is altered in DA-‘- mice, we performed im- 
munostaining. Figures 78 and 7D show that substance P 
immunoreactivity was reduced in both the cell bodies of 
striatal neurons and their terminals in substantia nigra pars 
reticulata relative to controls (Figures 7A and 7C). Similar 
results were observed for dynorphin (Figures 7E and 7F). 
However, we did not observe obvious change in intensity 
or pattern of enkephalin immunoreactivity in the DA-‘-sIri- 
atum (data not shown). These results suggest that DA 
signaling normally induces substance P and dynorphin 
expression in the striatum. 
Figure 3. TH lmmunostaining in the Frontal 
Brain, Midbrain, and Brainstem Region of Wild- 
Type and DA-‘- Brains 
Coronal sections at different levels from P16 
wild-type brain (A, C, and E) and untreated 
DA+ brain (6, D, and F) were stained with 
anti-TH antiserum. In wild-type brain, TH immu- 
nostaining was observed in the caudate puta- 
men, nucleus accumbens, and olfactory tuber- 
cle (A) and in the substantia nigra and ventral 
tegmental area of the midrain (C) and locus 
ceruleus(E). In DA+ brain, TH immunoreactiv- 
ity was observed in the noradrenergic brain- 
stem nuclei (F), but was undetectable in the 
midbrain DA neurons(B) and their terminals in 
the frontal brain (D). Abbreviations: 4V, fourth 
ventricle; ac, anterior commissure; Cb, cere- 
bellum; CPU, caudate putamen; Cx, cerebral 
cortex; LC, locusceruleus; LV, lateralventricle; 
NAc, nucleus accumbens; SNc. substantia ni- 
gra pars compacta; SNr, substantia nigra pars 
reticulata; Tu, olfactory tubercle; VTA, ventral 
tegmental area. Scale bars in (A) and (B), 1 
mm; in (C) and (D). 250 pm; in (E) and (F), 500 
pm. 
Hypoactivity of DA-‘- Mice 
By PIO-P15, spontaneous hypoactivity of DA-‘- pups be- 
came apparent. Within 15 min of a single injection of 
L-DOPA to these naive mice, they became very active and 
began feeding, which continued for a few hours, but by 
12 hr they were hypoactive again. To quantitate their motor 
activity, we placed rescued adult DA-/- mice in an activity 
chamber equipped with infrared beams, and their activity 
during the light phase of the light-dark cycle was mea- 
sured. Control mice (those wild-type or heterozygous for 
TH) traveled -23 mlhr, whereas untreated DA-‘- mice 
traveled only -3 mlhr. An intraperitoneal injection of 
L-DOPA, at a dose of either 25 or 50 mglkg, increased 
locomotion of DA-‘- mice 50- to lOO-fold to a level that 
exceeded that for controls (Figure 8A). Robust activity was 
apparent within 15 min, peaked at -I hr, and then de- 
cayed. By 4 hr, activity of DA-/- mice was - 25% of maxi- 
mum, and by 24 hr it was back to basal levels. The same 
doses of L-DOPA had no effect on locomotion of control 
mice (data not shown). The DA-‘- mice responded similarly 
to repeated injections of L-DOPA (Figure 8A). Stereotypi- 
cal movements such as grooming, sniffing, and rearing 
were quantified as single beam breaks in the activity cage. 
Normal mice produced - 700 stereotypical beam breaks 
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Figure 4. Postnatal Growth and Survival of DA ‘- Mice and Rescue 
by L-DOPA 
(A) Body weights of two untreated DA-‘- mice and two DA-’ mice 
injected twice daily with 50 mglkg L-DOPA, starting at day 15, are 
compared with weight of control mice (mean f SEM; n = 6). Death 
is indicated by a cross. 
(B) Survival of control and untreated DA-‘- mice. 
(Figure 8C). L-DOPA produced a slight increase in stereo- 
typical behavior in control mice (data not shown), but a 
4- to 5-fold increase in DA-‘- mice (Figure 8C). 
The amount of DA in the brains of DA-‘- mice 1 hr after 
injection of L-DOPA was - 38% of that in control mice; it 
fell to - 18% of controls by 4 hr and was back to basal 
levels by 24 hr (Figure 86). Thus, the half-life of DA in 
DA-‘- mice is less than 3 hr. 
Reversal of Adipsia and Aphagia of DA-‘- Mice 
by L-DOPA 
Untreated DA-‘- mice became runted and succumbed to 
death during postnatal week 3. DA-‘- mice would neither 
drink nor eat wet or dry food even when it was placed near 
them. As shown in Figures 9A and 9C, DA-‘- mice would 
virtually cease eating or drinking - 12 hr after the last 
L-DOPA injection. There was an attendant 25% loss of 
body weight during the next 3 days, and, if untreated, the 
mice would die during the next day or two (Figure 96). 
Readministration of L-DOPA after 3 days of withdrawal 
resulted in intense consumption of food and water, which 
exceeded that of similarly treated control mice by - 50% 
during the first few days (Figures 9A and 9C), and within 
3 days they regained their previous body weight (Figure 
9B). Food consumption of normal mice was unaffected by 
L-DOPA, but it reduced water intake by approximately the 
amount of fluid injected (Figures 9A and 9C). For these 
experiments, L-DOPA was administered twice a day at 50 
mglkg. The mice consumed considerably less food when 
the drug was given only once a day, but they could survive 
on that regimen. The rates of food and water consumption 
were maximal during the first 2 hr after L-DOPA adminis- 
tration, declined to -40% of that rate during the next 4 
hr, and were virtually nil thereafter (Figure 9D). These rates 
parallel brain DA-‘- content (see Figure 88). We conclude 
that DA is required for ingestive behaviors. 
Discussion 
The DA-‘- mice were also tested for their ability to re- DA neural circuits have been studied intensively because 
spond to the D2-specific agonist quinpirole and to the Dl- of their involvement in movement control, drug abuse, and 
specific agonist SKF 81297. Both compounds, at doses cognition. Our current understanding of the functions me- 
that either slightly increased (SKF 81297) or decreased diated by DA stems largely from studies involving lesions 
(quinpirole) locomotion of control mice, increased locomo- of specific neural tracts along with the responses of ani- 
tion of DA-‘- mice -40-fold, but not as much as L-DOPA mals to DA agonists and antagonists. Classical genetics 
(Figure 8A). Both compounds also increased stereotypical has not provided much insight. However, transgenic tech- 
activity of DA-‘- mice (Figure 8C). Higher doses of both nologies provide new ways to apply genetics to this compli- 
quinpirole and SKF 81297 did not increase motor output cated system. Recently, mice lacking the Dl or D2 recep- 
further (data not shown). Dl receptor-selective antagonist tors have been reported (Drag0 et al., 1994; Xu et al., 
SCH 23390 did not block the stimulatory effect of quinpir- 1994a; Saik et al., 1995). Systematic inactivation of the 
ole in DA-‘- mice, which dispels the possibility that the D2 genes for all the DA receptors will ultimately reveal the 
agonist might be activating both Dl and D2 receptors in 
these mice (data not shown). Instead, these results sug- 
gest that either Dl or D2 receptor stimulation increases 
motor activity in DA-‘+ mice. 
To assess the motor activity of DA-‘- mice further, we 
tested them on a Rota rod. They were able to balance on 
a stationary rod for at least 3 min, even when untreated. 
However, when the rod was rotating at 10 rpm, they fell 
off within 5 s even after many trials, whereas control mice 
could stay on a rotating rod for 90 s (the duration of the 
trial) after five trials. Injection of DA-‘- mice with L-DOPA 
improved their ability to balance on the rotating rod, al- 
though they were never as good as controls (Figure 8D). 
These results suggest that execution of more complicated 
motor behaviors that require integration of sensory inputs 
is impaired in DA-‘- mice. 
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Figure 5. TH and AADC lmmunostaining of 
Wild-Type and Mutant Brains 
Sections on left are controls, and those on right 
are from an untreated DA-‘- mice(P16). (A)-(D) 
are coronal, while (E)-(H) are sagittal. Sections 
were stained with antisera against AADC, ex- 
cept for (E) and (F), which were stained with 
antisera against TH. Note that normal AADC 
immunoreactivities were observed in both co- 
ronal and saggital sections of DA-‘- mutant 
brains (6, D, and H). Abbreviations are the 
same as Figure 3; mfb, medial forebrain bun- 
dle. Scale bar in (A) and (S), 1 mm; in (C)-(H), 
250 urn. 
contribution of each receptor subtype. However, one limi- 
tation of receptor inactivation is that it is an irreversible 
process. Hence, functional changes in the animals could 
reflect either deficits in signal transduction or develop- 
mental abnormalities. As an alternative, we eliminated the 
ability of the mice to synthesize DA, reasoning that we 
might be able to rescue some or all behavioral defects by 
providing agonists to activate various DA receptor sub- 
types. 
Targeting of TH Gene to the DBH Promoter 
We used a gene targeting approach rather than random 
integration of transgenes because our previous experi- 
ence with human DBH-/acZ transgenes suggested that, 
while the expression was observed in all expected cell 
types, there was some apparently inappropriate expres- 
sion in midbrain DA neurons (Mercer et al., 1991). Our 
analysis of mice with TH driven by the DBH promoter indi- 
cates that TH expression is restricted to cells that are 
known to synthesize NE. The amount of NE produced in 
both the periphery and the brain is approximately normal 
despite the presence of only a single copy of the TH gene. 
Mechanisms involving transcription, stabilization of TH 
mRNA, or activation of TH enzymatic activity could ac- 
count for the adequacy of a single DBH-TH allele. In princi- 
ple, DA-‘- mice could have been made in one step, by 
replacing the transcriptional regulatory elements of the 
TH gene with those from the DBH gene; however, the 
successful execution of that strategy requires knowing all 
the relevant regulatory elements of the DBH gene. There 
is a further advantage of the two-step strategy because 
in subsequent experiments TH can be targeted only to 
adrenergic or dopaminergic cells. 
Dopamine-Deficient Mice 
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Figure 6. The Striatum of Wild-Type and DA-‘- Mice 
Low power view of the striatum from coronal brain sections of a P16 wild-type mouse (A, C, E, and G) and an untreated DA-‘- mouse (B, D, F, 
and H). Sections ware stained with cresyl violet (A and B), with antisera against DARPP32 (C and D), and with digoxygenin-labeled DA Dl (E and 
F) and D2 receptor (G and H) RNA antisense probes. The structure and morphology of the striatum are preserved in DA-‘- mice (B, D, F, and H). 
The expression of DA Dl and D2 receptor mRNA and the rmmunostaining of DARPP32 are normal (D, F, and H). Abbreviations: cc, corpus 
callosum; other abbreviahons as Figure 3. Scale bar, 1 mm. 
Essentially Normal Development of Dopaminergic 
and Striatal Neurons in DA-‘- Mice 
Dopaminergic neurons arise in the ventral midbrain of the 
mouse at El0 in response to an inductive signal (Sonic 
hedgehog) from the underlying floorplate (Hynes et al., 
1995). During the next few days, DA neurons extend axons 
toward the developing striatum. By El4 (in the rat), this 
nigrostriatal tract reaches the striatal anlage at a time 
when only a few of the striatal neurons have been formed 
(Bayer, 1984; van der Kooy and Fishell, 1987). mRNAs 
for both Dl and D2 receptors and D2 ligand binding are 
already evident in the striatal primordium (Schambra et 
al., 1994). Thus, the ability to synthesize DA and a receptor 
system capable of responding to DA are present at the 
time that nigrostriatal connections are developing. Be- 
cause dopaminergic neurons also express D2 receptors, 
ablating DA signaling could affect the development of do- 
paminergic neurons as well as striatal neurons or nigrostri- 
atal synaptogenesis. 
The initial impression is that the number of DA neurons, 
their projections to striatum, and the morphological organi- 
zation of the striatum are normal, except that the levels 
of substance P and dynorphin in the striatum are reduced. 
Most importantly, when L-DOPA is administered to naive 
DA-/- mice, they respond dramatically, suggesting that 
functional connections have been established. Thus, we 
tentatively conclude that DA-mediated signaling is not re- 
quired for either neurogenesis of the striatum or the estab- 
lishment of functional nigrostriatal connections. This con- 
clusion is reinforced by previous studies on Dl and D2 
receptor knockout mice, perinatally 6-OHDA-lesioned 
rats, and transplantation of embryonic striatum into DA- 
depleted adult brain of mice (Liu et al., 1992a; Lauder, 
1993; Drago et al., 1994; Xu et al., 1994a; Baik et al., 
1995). However, it must be tempered by the possibility 
that some DA may reach the developing brain. Small 
amounts of circulating maternal DA could enter fetal circu- 
lation (Thomas et al., 1995) and be taken up by developing 
DA neurons. Alternatively, because DA-‘- mice produce 
DA as a precursor of NE in noradrenergic neurons, some 
might be secreted and utilized by DA neurons. Our direct 
chemical measurements of DA in the brain of untreated 
PI6 DA-‘+ mice indicate that it is <30/o of that in normal 
mice. 
DA and Activity 
The observation that DA-‘- mice are severely hypokinetic 
is consistent with akinesia in Parkinson’s disease, hypoac- 
tivity resulting from blockade of DA receptors, or destruc- 
tion of DA neurons by neurotoxins (Hornykiewicz, 1966; 
Ungerstedt, 1971; Arnt, 1987; Clark and White, 1987; 
Kopin and Markey, 1988; Zigmond and Stricker, 1989). 
The observation that neonatal DA-‘- mice are indistin- 
guishable from their littermates by postnatal week 1 indi- 
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Figure 7. Substance P and Dynorphin Immu- 
nostaining of Wild-Type and Mutant Brains 
Coronal sections of PI6 wild-type (A) and un- 
treated DA-‘- (B) brain were cut at the striatal 
level, whereas the wild type (C and E) and DA-‘- 
(D and F) were at midbrain level. (A)-(D) were 
stained with antisera against substance P, 
whereas(E) and (F) were stained with antisera 
against dynorphin B. Abbreviation: S, septum. 
Other abbreviations as in Figure 3. Scale bar 
in (A) and (B), 1 mm; in (C)-(F), 250 urn. 
cates that the limited movements that neonates make are 
not dependent upon DA. Thus, dopaminergic pathways 
achievedominantcontrolof activityonlyafterthefirstweek 
or so. Although detailed dose response experiments have 
not been performed with dopaminergic agonists, we pre- 
dict that DA receptors in DA-‘- mice will be hypersensitive 
compared with control mice because they would not be 
down-regulated. The excessive motor activities of DA-‘- 
mice during the first hour after treatment with dopaminer- 
gic agonists could reflect an increased number of DA re- 
ceptors that can be activated, as well as increased efficacy 
of G protein activation. 
Despite considerable evidence supporting the require- 
ment of Dl receptor stimulation for D2 receptor-mediated 
neurophysiological and behavioral responses (Clark and 
White, 1987; Waddington and Daly, 1993; Xu et al., 
1994b), we observed a significant improvement of locomo- 
tion and stereotypy in DA+ mice with low doses of a D2 
agonist, indicating that Dl stimulation is not required for 
D2-mediated behaviors in these mice. The similar re- 
sponse of these mice to both Dl and 02 agonists is con- 
sistent with models in which Dl and D2 receptors are in- 
corporated into parallel pathways (striatonigral and 
striatopallidal) such that opposite biochemical effects 
upon their activation result in similar neurophysiological 
and behavioral outputs (Albin et al., 1989; Alexander and 
Crutcher, 1990; Gerfen, 1992). This model, with two paral- 
lel output pathways, predicts that mice lacking either Dl 
or D2 receptors would have essentially normal basal motor 
activities. The Dl receptor knockout mice display either 
normal (Drag0 et al., 1994) or 2- to &fold enhanced activity 
(Xu et al., 1994a, 1994b), whereas D2 receptor knockout 
mice manifest 4-fold reduced locomotor activity (Baik et 
al., 1995). The combined results suggest that both motor 
output pathways can work independently, but synergy is 
achieved by coordinated activation of both pathways. The 
performance of DA-‘- mice in more complicated tasks, 
such as balance on a Rota rod, which requires the integra- 
tion of sensory inputs, was improved by the drug treat- 
ments, but not to normal levels. Perhaps this reveals an 
underlying developmental abnormality caused by DA defi- 
ciency before treatment with L-DOPA began. 
L-DOPA-responsive dystonias (DRDs) result from point 
mutations in either the TH gene or the cyclohydrolase gene 
required for synthesis of the biopterin cofactor (Ludecke 
et al., 1995; Nygaard, 1995). These mutations impair DA 
synthesis and thus reflect milder forms of the murine defi- 
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Figure 8. Locomotor and Stereotypical Activ- 
ity of DA-‘- Mice in Response to L-DOPA, Quin- 
pirole, and SKF 81297 
(A) Ambulation. Locomotion of DA ‘- mice 
(mean + SEM; n = 6) in a new environment 
is represented as the total distance traveled in 
60 min during the light phase. Drugs adminis- 
tered are indicated by arrows. The effects of 
L-DOPA were measured 1, 4, 24, and 48 hr 
after drug administration, whereas the effects 
of quinpirole (&in) and SKF 81297 were mea- 
sured 15 min after injection because these ago- 
nists do not require metabolic activation. 
(6) Stereotypy. Stereotypy index was calcu- 
lated by subtracting ambulatory counts from 
the total activity counts. 
(C) DA content. DA contents of whole brain of 
untreated control mice (n = 6) and DA-‘+ mice 
before (n = 1) and 1 hr (n = 2), 4 hr (n = 
2), and 24 hr (n = 1) after 50 mglkg L-DOPA 
injection were measured as in Figure 2. 
(D) Rota rod. The time that control mice (n = 
6) and DA-‘+ mice (n = 6) stayed on the Rota 
rod during a 90 s trial (10 rpm) was recorded. 
kinson’s patients, DRD patients respond to low doses of 
L-DOPA over a long period of time because DA neurons 
are intact. However, the twisting postures and movements 
that are characteristic features of DRD are not apparent 
in the DA-/- mice. Likewise, tremor, oneof the hallmarksof 
Parkinson’s disease, is present in MPTP-treated primates, 
but is not recognized in DA-‘- mice or in MPTP- or 6-OHDA- 
treated rodents (Bergman et al., 1990). These observa- 
tions probably reflect underlying differences in the utiliza- 
tion of dopaminergic pathways in rodents and primates. 
DA and Feeding Behavior 
Pioneering studies by Anand and Brobeck (1951) revealed 
that bilateral electrolytic lesions of the lateral hypothala- 
mus (LH) in rats produced profound aphagia, adipsia, and 
akinesia. The hypothesis that LH is an important center 
for feeding was further supported by the observations that 
lesions of intrinsic LH glutamatergic neurons by kainate 
or ibotenic acid produced persistent adipsia and aphagia, 
that electrical stimulation of LH stimulated feeding in sati- 
ated rats, and that electrical activities of hypothalamic neu- 
rons was correlated with feeding and drinking behavior 
(Grossman et al., 1978; Rolls, 1981; Winn et al., 1984). 
Early evidence that DA might be a critical player in the 
LH syndrome came from the demonstration that most 
symptoms of LH ablation could be reproduced by injecting 
6-OHDA into the LH or midbrain dopaminergic neurons of 
adult rats (Ungerstedt, 1971; Zigmond and Stricker, 1972; 
Fibiger et al., 1973). Surprisingly, especially in view of 
our results, neonatal lesions of rats with 6-OHDA have 
relatively mild effects on behavior and electrophysiology, 
despite >99% depletion of DA (Onn et al., 1990). Pharma- 
cological experiments tend to support a role for DA in feed- 
ing in that DA agonists stimulate, whereas antagonists 
inhibit, feeding and drinking (Phillips and Nikaido, 1978; 
Dourish, 1983; Salamone et al., 1990), although contrary 
results have been obtained (Cooper and Al-Nasar, 1993). 
Relatively mild feeding deficits were observed in Dl or D2 
receptor-deficient mice, and they grew to 70% or 85% of 
normal body weight, respectively (Drag0 et al., 1994; Xu 
et al., 1994a; Baik et al., 1995). We provide compelling 
evidence that DA is essential for feeding and drinking be- 
havior. When DA-/- mice are born, they initiate suckling 
behaviors and nurse effectively enough to almost triple 
their birth weight. However, after 2 weeks, when normal 
mice would begin to explore other sources of nourishment, 
the DA-‘- mice become lethargic and fail to eat and drink. 
The role that DA plays in feeding and drinking behaviors 
is not established. Dopaminergic pathways could be re- 
quired for the perception of hunger and thirst. Multiple 
connections between LH and midbrain DA neurons have 
been identified (Bunney and Aghajanian, 1976; Phillipson, 
1979; Wright et al., 1980). Dopaminergic innervation might 
control the responsiveness of LH to interoceptive stimuli 
(Marrocco et al., 1994); i.e., dopaminergic tone could de- 
termine the threshold of hunger and thirst. In the absence 
of dopaminergic stimulation, the threshold may become 
so high that DA-‘- mice do not perceive a need to eat or 
drink. There is evidence supporting a role of DA in de- 
termining the responsiveness to external stimuli (Braff and 
Geyer, 1990). 
Alternatively, DA could be required for the motor execu- 
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Figure 9. Adipsia and Aphagia of DA-‘- Mice 
and Reversal by L-DOPA 
(A) Comparison of food intake of DA-‘- mice 
(mean f SEM; n = 6)andcontrol mice(n = 
6) with or without L-DOPA. L-DOPA was not 
administered between the two arrows. Vehicle 
injection did not stimulate feeding in DA-‘- 
mice. 
(B) Body weights of the same group of DA-‘- 
mice represented in (A) are shown. A different 
group of mice (n = 5) was tested for their ability 
to survival without L-DOPA. The cross indi- 
cates their death. 
(C) Comparison of water intake of DA-” mice 
(n = 6) and control mice (n = 6) with or without 
L-DOPA. L-DOPA was not given between the 
two arrows. Vehicle injection did not stimulate 
drinking in DA-‘- mice, 
(D) Consumption of food and water by DA-‘- 
mice (n = 6) after single L-DOPA injection 
0 2 4 6 6 10 12 14 16 10 
Dayr 
2-6 6-24 
Tim6 after L-DOPA (hr) 
tion of feeding in response to signals from the hypothala- A third possibility is that the adipsia and aphagia in the 
mus. Regional 6OHDA lesions in the ventrolateral stria- DA-‘- mice is related to deficiency in reward mechanism 
turn (but not other regions of the striatum) depress feeding mediated by the mesolimbic dopaminergic systems. The 
transiently (Jicha and Salamone, 1991). Transplantation application of three reward study procedures (intracranial 
of nigral tissue into the striatum of neonatal rats protected self-stimulation, intravenous self-administration, and con- 
against adipsia and aphagia when the endogenous nigro- ditioned place preference) has generated a substantial 
striatal tracts were subsequently lesioned by 6-OHDA in body of evidence indicating that mesolimbic DA neurons 
adults (Schwarz and Freed, 1987). However, the place- are an important link in the neural circuitry of reward (re- 
ment of the grafts was critical, presumably to allow effec- viewed by Fibiger and Phillips, 1988; Koob, 1992; Wise 
tive connections with the hypothalamus (Rogers et al., and Hoffman, 1992). Hebb (1955) suggested that brain 
1990). Furthermore, partial lesions of the striatum by kai- reward circuits may have evolved to reinforce survival be- 
nate depressed eating and drinking, and bilateral lesions haviors such as feeding. Supporting evidence exists that 
of nuclei globus pallidus and mesencephalic reticular for- the mesolimbic dopaminergic system is involved in food- 
mation caused aphagia and adipsia (Morgane, 1961; Par- rewarded behavior. For example, feeding stimulates DA 
ker and Feldman, 1967; Pettibone et al., 1978). The com- turnover in the nucleus accumbens (Hernandez and 
bined results of these experiments suggest that normal Hoebel, 1988a, 1988b; Smith and Schneider, 1988; Jo- 
execution of feeding and drinking behavior requires the seph and Hodges, 1990), DA receptor blockers impair the 
interaction of intrinsic LH neurons, dopaminergic neurons, reinforcement value of food (Wise et al., 1978), and inhibi- 
striatal neurons, and neurons of midbrain reticular forma- tion of TH activity in the ventral tegmental area with anti- 
tion. An important question is whether adipsia or aphagia sense oligonucleotides inhibits food pellet-conditioned 
is simply secondary to motor deficits. Although we cannot operant behavior (Skutella et al., 1994). Thus, in this sce- 
answer this question definitively, we think it is unlikely nario, eating and drinking are not perceived as rewarding 
because DA-‘- mice can grasp food and swallow liquid experiences and are subsequently extinguished in DA-‘- 
food when put in their mouths. mice. 
Dopamine-Deficient Mice 
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Other techniques will be necessary to determine which 
dopaminergic pathways are involved in the various behav- 
ioral deficits; however, these DA-‘- mice provide ideal re- 
cipients for intracranial deliver), of DA agonists, DA- 
producing cells, or TH genes to specific brain regions. 
Experimental Procedures 
lmmunohistochemistry and In Situ Hybridization 
For immunohistochemical studies, untreated mice 15-21 days old 
were sacrificed by CO, inhalation. Brains were fixed in 4% paraformal- 
dehyde for 6-24 hr at 4% and soaked in 20% sucrose overnight, 
frozen, and cut on a freezing microtome at 20-30 pm. Free-floating 
sections were stained according to standard streptoavidin immunohis- 
tochemical procedures (Xu et al., 1994a). Primary antisera included 
the following: monoclonal mouse antiserum against TH diluted 1 :I000 
(IncStar Corporation), monoclonal mouse antiserum against DARPP32 
diluted 1:10,000. polyclonal rabbit antiserum against substance P di- 
luted 1:5,000, polyclonal rabbit antiserum against rat dynorphin B 
diluted 1:2,000, polyclonal rabbit antiserum against met-enkephalin 
diluted 1 :lOOO, and polyclonal rabbit antiserum against AADC diluted 
1:2000. If no primary antibody was applied, no specific immunostaining 
was observed. In situ hybridization with digoxygenin-labeled Dl and 
D2 riboprobes was performed according to the method of Wilkinson 
and Nieto (1993). 
Rescue, Feeding, and Drinking Experiments 
L-DOPA (Sigma) was dissolved in saline solution (1.5 mglml) con- 
taining 0.25% ascorbic acid as antioxidant, filtered, aliquoted, and 
kept at -20%. DA-‘- pups, which were usually noticed by P14, were 
injected intraperitoneally twice a day at a dose of 50 mglkg or 33 ml/ 
kg body weight. Body weights were measured daily, and genotypes 
were determined by Southern blotting. Food and water were available 
ad lib; water and food consumption during were calculated from differ- 
ential weights. 
Motor Behavior 
For locomotion activities, two to four mice (7-l 1 weeks of age) were 
placed in a transparent Plexiglas cage (28 cm x 17 cm x 11.5 cm) 
for 1 hr of habituation. Animal activity was monitored in an Qpto-Vari 
system (Columbus Instruments) during the light phase of the light- 
dark cycle. Stereotypy was calculated by subtracting the ambulatory 
counts from the total counts. Distance traveled was calculated by multi- 
plying the ambulatory counts by 2.65 cm (the distance between 
beams). The motor stimulatory effectsof L-DOPA, quinpirole. and SKF 
61297 (Research Biochemical Incorporated) were tested at various 
times afler injection. The same group of mice was used for all three 
drugs. Experiments with each drug were separated by at least 3 days, 
and the mice were maintained with L-DOPA between experiments. 
Testing was begun 16 hr after last injection of L-DOPA. Quinpirole 
and SKF 61297 were administered intraperitoneally in 10 ml/kg body 
weight. For the Rota rod (rod, 4 cm in diameter; manufactured by 
Jones and Roberts) experiments, control and DA-‘- mice were injected 
with L-DOPA and trained four times during the next hour at IO rpm 
prior to the experiment. 
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